Saturday, February 15, 2014 10:43:34 AM
Email from Andy Fellner:
Good morning
As you are aware, I can't discuss anything that is not public record, but there are things I can respond too that
may make what the company is doing make more sense to you and other shareholders.
To begin, I do not have control over the investors that are buying shares at $.0001 so there is nothing I can do or say to make them buy or sell shares on the open market. It is strictly their own decision as to what to do and when,
I do want to make it clear that I am not selling shares of any kind on the open market, in fact, I have not sold a single share of my own stock since I started the company in May of 2010, nor have I received any salary and I have loaned the company hundreds of thousands of dollars to continue operations.
I have tried to raise money for the company since its inception and was successful for a while but toward the end of last year the company was nearing collapse which can be verified by looking at the year end financial statements filed with the OTC and I could no longer support it, so it was either raise money or close the company down.
I chose to raise money instead of ceasing operations and am doing it with the Reg A that was approved by the SEC on January 17, 2014. The shares being sold are through this Reg A so not only has the SEC seen the Offering, they commented on it and eventually approved it so they are well aware that the company is selling shares at $.0001 as they are the ones that allowed the company to do so,
If people want to file claims with the SEC, that is fine as I am doing nothing wrong and in fact I am doing what I am supposed to do which is raise money so that company continues to operate for the benefit of the shareholders.
I hope you and other shareholders will begin to see why I am doing what needs to be done or the company would be out of business and the shares would be worthless. At least doing it this way, everyone has a chance to eventually benefit because the company is still operating.
Sincerely,
Andrew Fellner
President
STBV
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM